A New Idea to Treat Glioma with Mulberin

doi:10.3969/j.issn.2095-1396.2019.05.009

Abstract

Abstract:

Glioma is the primary brain tumor generated by cancerous brain and spinal cord glial cells. It’s the most common malignant tumor，comes from neuroepithelial cells and is mainly caused by EGF receptor mutation. Glioma cells also secrete VEGF factors，which can lead to more serious consequences. Currently，the treatments for the disease include surgery， radiotherapy，chemotherapy and other means，however，it can only relieve the symptoms，be completely cured hardly and often relapse. In recent years，the researches of drug therapy have not been stopped. Morus alba L is the root bark of Morus alba L， which is mainly used for treating lung heat，wheezing and phlegm，stopping lung by drinking water，and wheezing and acute wheezing after swelling. The Mulberin extracted from Morus alba L is the mainly active ingredient. Studies have shown that Mulberin has a certain effect on EGF in cancer cells，which in turn affects the expression of EGF receptor. Mulberin also has a certain effect on VEGF，so it can be used to treat Glioma by affecting EGF and VEGF. This article reviewed the development status of Glioma，the research of Mulberin and its effect on EGF and VEGF. In the meantime，a new idea of treating Glioma with Mulberin is proposed based on above of conclusions.

Key words: Glioma, EGF, Morus alba L, Mulberin

CLC Number:

R964

ZHAO Peng-hui，PANG Ce，ZHEN Pan. A New Idea to Treat Glioma with Mulberin[J]. Acta Neuropharmacologica, DOI: 10.3969/j.issn.2095-1396.2019.05.009.

References

[1] 茹琴, 田香, 陈琳, 等. 大鼠神经胶质瘤和嗜铬细胞瘤中P2X受体的表达特征研究[J]. 神经药理学报, 2012, 2(4): 1-7.
[2] 苏晓梅, 张丹参. Angiopep-2修饰的装载不同药物的纳米系统在胶质瘤中的应用[J]. 神经药理学报, 2015, 5(6): 57-63.
[3] Yojiro Akagi, Koji Yoshimoto, Nobuhiro Hata, et al. Reclassification of 400 consecutive glioma cases based on the revised 2016 WHO classification[J]. Brain Tumor Pathology, 2018, 35(2):1-9.
[4] Yoshiko Nakano, Arata Tomiyama, Takashi Kohno T, et al. Identification of a novel KLC1–ROS1 fusion in a case of pediatric low-grade localized glioma[J]. Brain Tumor Pathology, 2018,36(1):1-6.
[5] Jin Woo Bae, Eun Kyung Hong, Ho-Shin Gwak. Response of leptomeningeal dissemination of anaplastic glioma to temozolomide: experience of two cases[J]. Brain Tumor Research & Treatment, 2017, 5(2):99-104.
[6] Christian Engwer, Markus Knappitsch, Christina Surulescu. A multiscale model for glioma spread including cell-tissue interactions and proliferation[J]. Mathematical Biosciences & Engineering Mbe, 2017, 13(2):443-460.
[7] 张学锋, 李建东. 经胎盘诱发大鼠脑肿瘤抑癌基因p21的表达[J]. 神经药理学报, 2002, 19(5):8-10.
[8] 汤恒. 系统的规范化护理对脑胶质瘤手术患者效果和应激反应的影响[J]. 实用临床护理学电子杂志, 2019(8):96-97.
[9] 黄娜, 郭昱琪, 程伟鹤. 脑功能区胶质瘤病人术后失语的超早期护理干预效果研究[J]. 护理研究, 2019,33(01):138-141.
[10] 术中超声及造影引导脑胶质瘤手术及患者远期疗效的观察 [C] 中国超声医学工程学会第十四届全国颅脑及颈部血管超声学术大会论文汇编, 2018.
[11] 单体华, 李宏. 显微外科手术在脑胶质瘤患者中的应用效果观察[J]. 中国卫生标准管理, 2018(7):44-46.
[12] Da-Peng Yun, Wang Yu-qi, Meng De-long, et al. Actin-capping protein CapG is associated with prognosis, proliferation and metastasis in human glioma[J]. Oncology Reports, 2018, 39(3):1011-1022.
[13] Wang Rui, Wei Jun, Li Zhao-hui, et al. Bioinformatical analysis of gene expression signatures of different glioma subtypes[J]. Oncology Letters, 2018, 15(3):2807-2814.
[14] Macarthur B D, Please C P, Pettet G J. A mathematical model of dynamic glioma–host interactions: receptor-mediated invasion and local proteolysis[J]. Mathematical Medicine & Biology A Journal of the Ima, 2018, 22(3):247-264.
[15] 查昳琳, 徐晓婷. 多模态MRI在高级别脑胶质瘤放疗中的应用[J]. 中华放射肿瘤学杂志, 2019, 28(3):226-229.
[16] 李靖远, 许在华, 孙靖驰, 等. 脑胶质瘤EGFR基因及对放化疗预后的影响[J]. 中华神经外科疾病研究杂志, 2018, 17(1):32-34.
[17] 郭昭宇, 史昱国, 郭丝锦. 脑胶质瘤术后患者调强放疗+替莫唑胺治疗的临床效果[J]. 临床医学研究与实践, 2018, 3(31):35-37.
[18] 孙伟, 刘卫东, 龚良, 等. 白藜芦醇增强5-氨基酮戊酸在人脑胶质瘤细胞中的光动力治疗作用[J]. 临床神经外科杂志, 2019, 16(01):27-32.
[19] 唐志鹏, 夏春义, 李沿东, 等. 槲皮素对脑胶质瘤C6细胞增殖的调控作用[J]. 解剖科学进展, 2019, 25(01):65-67+71.
[20] 扈丹丹, 刘肖莹, 李明慧, 等. 纳米技术治疗脑胶质瘤的研究进展[J]. 中国医药导报, 2018, 15(12):31-33.
[21] 房波. 杨梅黄酮抑制人脑胶质瘤迁移、侵袭和血管生成的机制研究[D]. 吉林：吉林大学, 2018.
[22] 蒋洪庆, 金昱. 脑胶质细胞瘤中EGFR扩增与突变对PI3K/AKT信号通路mRNA表达的影响[J]. 延边大学医学学报, 2015, 38(2):79-82.
[23] 骆竹媚, 周从明, 李平, 等. 脑胶质瘤中P53,MGMT,EGFR的表达及临床意义[J]. 四川医学, 2014, 35(5):551-554.
[24] 周伟, 赵洪洋, 姜晓兵, 等. NF-κB、EGFR、PCNA在人脑胶质瘤细胞中的表达及其相关性研究[J]. 中国临床神经外科杂志, 2004, 9(4):255-258.
[25] 陶胜忠. 胶质瘤放射敏感性与ATM蛋白表达关系的实验研究[D]. 武汉：华中科技大学, 2005.
[26] Nicholson R I, Gee J M, Harper M E. EGFR and cancer prognosis[J]. European J Cancer, 2001, 37(14):9-15.
[27] 孔月月, 饶国武. 第三代EGFR抑制剂研究进展[J]. 浙江化工, 2019, 50(1): 18-26.
[28] 张云强, 刘正泉, 薄爱华. EGFR在乳腺良、恶性肿瘤中过表达的临床意义[J]. 神经药理学报, 2010, 27(2):21-22.
[29] 李海峰, 张晓丽, 薄爱华,等. EGFR在乳腺癌中的表达及意义[J]. 神经药理学报, 2006, 23(2):18-19.
[30] Zhu Hong-fan, Chen Dian-gang, Tang Jin-liang, et al. Overexpression of centrosomal protein 55 regulates the proliferation of glioma cell and mediates proliferation promoted by EGFRvIII in glioblastoma U251 cells[J]. Oncology Letters, 2018, 15(2):2700.
[31] Blandin A F, Mercier M C, Choulier L, et al. PO-132 Alpha5 beta1 integrin provides glioma cell resistance to EGFR tyrosine kinase inhibitors. role of membrane trafficking [C] Biennial Congress of the European Association for Cancer Research. 2018.
[32] Xing S, Yingjie S, Tianwei J, et al. Radiation upregulates PD-L1 through the pathways downstream of EGFR in glioma [C] 第十二届全国免疫学学术大会摘要汇编. 2018.
[33] Sun Li-li, Yu Shu-ye, Xu Hui, et al. FHL2 interacts with EGFR to promote glioblastoma growth[J]. Oncogene, 2018, 37(10):0068.
[34] Pan Yuan-bo, Zhang Chi-hao, Wang Si-qi, et al. Transforming growth factor beta induced (TGFBI) is a potential signature gene for mesenchymal subtype high-grade glioma[J]. Journal of Neuro-oncology, 2018, 137(2):1-13.
[35] Wang Chen-long, Li Ying, Chen Hong-lei, et al. CYP4X1 inhibition by flavonoid CH625 normalizes glioma vasculature through reprogramming TAMs via CB2 and EGFR-STAT3 axis[J]. Journal of Pharmacology & Experimental Therapeutics, 2018, 365(1):72-83.
[36] Yang Chao, Li Yan-sheng, Wang Qi-xue, et al. EGFR/EGFRvIII remodels the cytoskeleton via epigenetic silencing of AJAP1 in glioma cells[J]. Cancer Letters, 2017, 403: 119-127.
[37] 张凡, 张九鸿, 段彩霞, 等. Ki-67、VEGF、CD34表达与病理类型相关性的研究[J]. 神经药理学报, 2006, 23(6):1-5.
[38] 吴兴茂, 廖玉巍, 张铭琏. 胆管癌中p27Kip1、VEGF的表达、意义及相互关系[J]. 神经药理学报, 2003, 20(2):6-8.
[39] 芦广萍, 闫爱春, 薄爱华, 等. 血管内皮生长因子在乳腺良、恶性肿瘤表达的临床意义[J]. 神经药理学报, 2007, 24(5):27-28.
[40] 张梦飞, 项丽玲, 曹利华, 等. 毛冬青总黄酮对大鼠局灶脑缺血再灌注模型的影响[J]. 神经药理学报, 2016, 5(5):3-15.
[41] 张涛, 王辉, 杨晓文. 脑胶质瘤中Id1与VEGF的表达及其与肿瘤血管生成的关系[J]. 解剖学研究, 2018, 40(05):24-27+36.
[42] 石凤云, 佟建洲. VEGF、ILK、CD151在肿瘤血管生成及胶质瘤中的研究进展[J]. 承德医学院学报, 2017, 35(5):422-424.
[43] 李鑫, 马建华, 戴宜武. VEGF、Sox-2、CXCR4在不同病理分级脑胶质瘤中的表达差异及临床意义[J]. 中国现代医药杂志, 2018, 20(10):7-9.
[44] 关婷婷, 王小宜, 侯磊, 等. DCE-MRI与脑胶质瘤级别及VEGF关系的研究[J]. 临床放射学杂志, 2018, 37(12):25-31.
[45] 李墨灵, 张晗, 夏庆梅. 桑白皮的化学、药理与药代动力学研究进展[J]. 西部中医药, 2017, 30(2):137-139.
[46] Hironobu Uchiyama, Ken-Ichi Komatsu, Akifumi Nakata, et al. Global Liver Gene Expression Analysis on a Murine Hepatic Steatosis Model Treated with Mulberry (\r, Morus alba\r, L.) Leaf Powder[J]. Anticancer Research, 2018, 38(7):4305-4311.
[47] 郭伟强, 王硕, 李军, 等. 川桑中桑皮素、桑呋喃A和总黄酮的测定[J]. 中成药, 2016, 38(11):2506-2509.
[48] 杨春涛. 热带假丝酵母与桑叶黄酮对犊牛生长和胃肠道发育的影响[D]. 北京：中国农业科学院, 2016.
[49] 黄德彬, 胡泽华, 余昭芬, 等. 马桑提取物促进大鼠烧伤创面愈合的作用和机制[J]. 中国病理生理杂志, 2013, 29(1):138-144.
[50] 左亚奇, 王静, 郭伟强,等. 桑皮素对人前列腺癌Du145细胞的抑制作用[J]. 中药药理与临床, 2018, 194(2):37-41.
[51] 郭伟强. 川桑中桑皮素的含量测定及其对ECA109和Du145细胞株的抑制作用[D]. 张家口：河北北方学院, 2017.